Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Mary-Ellen Taplin

(18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer

scientific article

A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer

scientific article published on 28 September 2016

A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy

scientific article published on 4 April 2016

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

scientific article

A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer

scientific article published on 22 October 2014

A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.

scientific article published in May 2008

Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment

scientific article published on 20 July 2018

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3

scientific article published on 16 January 2015

Abiraterone acetate: targeting persistent androgen dependence in castration-resistant prostate cancer

scientific article published on 27 August 2013

Abiraterone in metastatic prostate cancer without previous chemotherapy

scientific article published on 10 January 2013

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

scientific article

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib

scientific article

Activity of dutasteride plus ketoconazole in castration-refractory prostate cancer after progression on ketoconazole alone

scientific article published in October 2009

Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer

scientific article published on 23 October 2009

Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura

scientific article

American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer

scientific article

Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer

scientific article published on 20 April 2018

Androgen Receptor Antagonists

article

Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer

scientific article published on 2 November 2015

Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

scientific article

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence

scientific article published on February 2004

Androgen receptor: role and novel therapeutic prospects in prostate cancer

scientific article published on September 2008

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study

scientific article

Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer.

scientific article published on 7 April 2017

Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy

scientific article published on 23 June 2016

Atypical metastases from prostate cancer: 10-year experience at a single institution

scientific article published on August 2012

Biochemical (Prostate-Specific Antigen) Relapse: An Oncologist's Perspective.

scientific article published on January 2003

Biochemical (Prostate-Specific Antigen) Relapse: An Oncologist's Perspective.

scientific article published in January 2003

Case Report: Responses to Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer After Extensive Docetaxel Treatment ⬇️

scientific article published on August 3, 2011

Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687.

scientific article published on 29 January 2015

Clinical Outcomes of Chemotherapy Naïve Men with Metastatic Castration Resistant Prostate Cancer and Low Baseline Prostate Specific Antigen Treated with Enzalutamide vs Placebo

scientific article published on 20 July 2017

Clinical Outcomes of First-line Abiraterone Acetate or Enzalutamide for Metastatic Castration-resistant Prostate Cancer After Androgen Deprivation Therapy + Docetaxel or ADT Alone for Metastatic Hormone-sensitive Prostate Cancer

scientific article published on 27 December 2017

Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease

scientific article published on 29 May 2013

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

scientific article published in December 2017

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options

scientific article published on 10 January 2018

Detecting metastatic prostate carcinoma in pelvic lymph nodes following neoadjuvant hormone therapy: the eyes have it!

scientific article

Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum ⬇️

scientific article published on July 10, 2013

Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

scientific article published on 22 April 2015

Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer

scientific article published on 01 December 2006

Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer

scientific article published on 19 December 2011

Drug insight: role of the androgen receptor in the development and progression of prostate cancer

scientific article published on April 2007

Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center

scientific article

Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls

scientific article published on February 2014

Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer

scientific article

Efficacy of Therapies After Galeterone in Patients With Castration-resistant Prostate Cancer.

scientific article

Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer

scientific article

Enzalutamide for the treatment of prostate cancer: results and implications of the AFFIRM trial

scientific article published on February 2014

Enzalutamide in metastatic prostate cancer before chemotherapy

scientific article published in June 2014

Evaluating a Video-Based, Personalized Webpage in Genitourinary Oncology Clinical Trials: A Phase 2 Randomized Trial

scientific article published on 02 May 2019

Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.

scientific article published on April 2006

Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide

scientific article published on 11 September 2017

Genetic Effect of Chemotherapy Exposure in Children of Testicular Cancer Survivors

scientific article published on 2 December 2015

Genomic correlates of clinical outcome in advanced prostate cancer

scientific article

Has the Time Arrived for Biomarker-Directed Therapy in Castration-Resistant Prostate Cancer?

scientific article published on 4 June 2015

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

scientific article published on 06 July 2016

Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer

scientific article

Integrative Clinical Genomics of Advanced Prostate Cancer

scientific article

Integrative clinical genomics of advanced prostate cancer

scientific article

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study

scientific article

Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel

scientific article published on 9 December 2014

Long-term Follow-up of a Phase II Trial of Chemotherapy Plus Hormone Therapy for Biochemical Relapse After Definitive Local Therapy for Prostate Cancer

scientific article published in March 2013

Long-term Safety and Antitumor Activity in the Phase 1-2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate Cancer

scientific article published on 16 February 2015

Metastatic Castration-Sensitive Prostate Cancer: Optimizing Patient Selection and Treatment

scientific article published on 01 May 2018

Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial

scientific article

Neoadjuvant Enzalutamide Prior to Prostatectomy

scientific article published on 9 November 2016

Novel agents and new therapeutics in castration-resistant prostate cancer ⬇️

scientific article published on May 1, 2011

Optimizing bone health and minimizing skeletal morbidity in men with prostate cancer

scientific article

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial

scientific article published on 26 January 2012

Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response ⬇️

scientific article published on July 15, 2011

Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer

scientific article

Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer

scientific article

Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer

scientific article published on 29 August 2012

Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade

scientific article published on 20 December 2017

Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer--a Cancer and Leukemia Group B study

scientific article

Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies

scientific article published on 24 October 2015

Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study

scientific article published in August 2005

Prostate cancer: Developing novel approaches to castration-sensitive disease

scientific article published on November 2016

Quality of Life and Pain in Advanced Stage Prostate Cancer: Results of a Southwest Oncology Group Randomized Trial Comparing Docetaxel and Estramustine to Mitoxantrone and Prednisone

scientific article published on 01 June 2006

Radium-223 Use in Clinical Practice and Variables Associated With Completion of Therapy

scientific article

Rationale for and Review of Neoadjuvant Therapy Prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer ⬇️

scientific article published on September 1, 2013

Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy

scientific article

Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer

scientific article

SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer

scientific article

Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion

scientific article published on 25 April 2017

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors

scientific article published on 3 June 2015

Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer

scientific article published on 02 October 2018

Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline

scientific article

Targeted androgen pathway suppression in localized prostate cancer: a pilot study

scientific article

Testicular vs adrenal sources of hydroxy-androgens in prostate cancer

scientific article

The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer

scientific article published on 13 December 2014

The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on Prostate-Specific Antigen and Radiographic Disease Progression in Patients with Non-Metastatic Castration-Resistant Prostate Cancer.

scientific article published on 6 April 2018

The Ingredients for Prostate Cancer Nomograms: The Addition of Biomarkers Sets the Table for Future Recipes

article

The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer ⬇️

scientific article published on May 1, 2012

The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer

scientific article published on August 2017

Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC)

article by Edoardo Francini et al published September 2018 in The Prostate

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

scientific article published on March 2009

Treatment With Galeterone in an Elderly Man With Castration-Resistant Prostate Cancer: A Case Report

scientific article published on 31 December 2014

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

scientific article

Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).

scientific article published on 6 March 2014

Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location

scientific article published on March 2011

Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

scientific article

Paulina is supported by:

About Paulina

Help